Phillip Okwo: The Crisis of Living Life Interrupted by Sickle Cell Disease
A sickle cell patient takes center stage to share with healthcare providers what it’s truly like living through a vaso-occlusive crisis.
Related Articles
Peanut IgE Stronger Predictor of Remission Than Age After Oral Immunotherapy
In this analysis, baseline peanut sIgE was shown to be a stronger predictor of remission after peanut OIT than age at the beginning of immunotherapy…
Potassium Nitrate for HFpEF Lacks Benefit for Exercise Capacity, Quality of Life
Potassium nitrate increased blood nitric oxide metabolites but showed no improvement in exercise tolerance or quality of life in a population with HFpEF.
Cardiology Year in Review: 2024
This listicle highlights 5 major approvals and 5 trial updates in cardiovascular care from 2024.
Peanut IgE Stronger Predictor of Remission Than Age After Oral Immunotherapy
In this analysis, baseline peanut sIgE was shown to be a stronger predictor of remission after peanut OIT than age at the beginning of immunotherapy…
COVID-19 May Increase Risk of Vitiligo, Chronic Urticaria, Alopecia Areata
These data highlight long-term complications related to COVID-19 in terms of skin conditions, a continuing concern for many patients.
Phase 3 KOASTAL-1 Trial Fails to Show Navacaprant Significantly Improves MDD
Although the oral navacaprant 80 mg failed to bring statistically significant improvements in depression symptoms, the study showed females respond better than males.
Allergy Year in Review: 2024
The field of allergy medicine this year saw a variety of developments, including the FDA approvals of neffy and omalizumab as well as new data…
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Rani discussed an in-depth study examining quality of sleep and quality of life in children and adolescents with SCD.
CASPAR Criteria May Identify More Patients With Juvenile PsA Than ILAR Criteria
A prospective study also found that the presence of psoriasis and dactylitis at disease onset were the strongest predictors for the development of PsA.
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Iron deficiency is currently screened at a ferritin threshold of 15 ug/mL, well below an accepted 25 ug/mL threshold.